Alterity Therapeutics Limited
ATH
Rank in Stocks
#26104
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Share Price
$0.18513726
Market Cap
$40.45M
Change (1 day)
2.94%
Change (1 year)
-47.10%
Country
AU
Trade Alterity Therapeutics Limited (ATH)
Category
Healthcare
Stock price history for Alterity Therapeutics Limited (ATH)
Highest end of day price: $0.33 on 2026-10-01
Lowest end of day price: $13.50 on 2012-09-01
Lowest end of day price: $13.50 on 2012-09-01
Stock price history of Alterity Therapeutics Limited from 2012 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -12.05% |
| 2025 | 75.00% |
| 2024 | -18.18% |
| 2023 | -37.61% |
| 2022 | -59.70% |
| 2021 | -39.12% |
| 2020 | 63.99% |
| 2019 | -39.67% |
| 2018 | -32.87% |
| 2017 | 8.20% |
| 2016 | -48.69% |
| 2015 | -55.45% |
| 2014 | -69.99% |
| 2013 | 162.07% |
| 2012 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $526.74 | 23.57% |
US
|
|
| $254.20 | 824.70% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.38 | 6.66% |
NL
|
|
| $752.87 | 7.40% |
CH
|
